Saturday, December 05, 2020 3:59:02 PM
Enzolytics holds several patents and has a solid foundation to move on with new drug manufacturing as immune system killing diseases have been flourishing thousands of years ago. Recent AIDS and HIV plagues force biotech firms to come up with optimal solutions to extend the patients’ lives. For industrial use, the company makes different bioproducts to defend civil and military objects anywhere. This segment may boost revenue in the near future as well.
https://ownsnap.com/volatility-cant-defeat-enzolytics-otc-enzc-in-december-amid-successful-merger-with-bioclonetics-immunotherapeutics/
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM